Primary synovial sarcoma of the kidney: A case report of complete pathological response at a Lebanese tertiary care center

dc.contributor.authorEl-Chediak, Alissar
dc.contributor.authorMukherji, Deborah M.
dc.contributor.authorTemraz, Sally N.
dc.contributor.authorNassif, Samer R.
dc.contributor.authorSinno, Sara A.J.
dc.contributor.authorMahfouz, Rami A.R.
dc.contributor.authorShamseddine, Ali I.
dc.contributor.departmentInternal Medicine
dc.contributor.departmentPathology and Laboratory Medicine
dc.contributor.facultyFaculty of Medicine (FM)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T11:52:06Z
dc.date.available2025-01-24T11:52:06Z
dc.date.issued2018
dc.description.abstractBackground: Primary synovial sarcoma of the kidney is a rare type of soft tissue sarcoma. Its presenting features can resemble those of other renal tumors; rendering its early diagnosis, a dilemma. Several cases of renal synovial sarcoma have been reported in the literature with varying treatment options and outcomes. This article describes a rare case of primary renal synovial sarcoma and reviews all cases in the literature. Case presentation: A 26-year-old male presented with flank pain and hematuria. Initially diagnosed with Wilm's tumor, revision of pathology and histology, along with the immunohistochemical profile, confirmed, nevertheless, the diagnosis of primary monophasic synovial sarcoma of the kidney with the SYT-SSX2 fusion transcript. Follow-up, post nephrectomy, revealed recurrence within the lungs and at the surgical bed. Surgical resection followed by adjuvant chemotherapy regimen constituting of Doxorubicin and Ifosfamide, achieved complete pathological response. Conclusion: In this case report, we emphasize the need for accurate diagnosis and prompt treatment. We propose multimodality treatment approach including surgery along with anthracycline-based chemotherapy to induce complete remission. © 2018 The Author(s).
dc.identifier.doihttps://doi.org/10.1186/s12894-018-0358-z
dc.identifier.eid2-s2.0-85046879322
dc.identifier.pmid29751751
dc.identifier.urihttp://hdl.handle.net/10938/31040
dc.language.isoen
dc.publisherBioMed Central Ltd.
dc.relation.ispartofBMC Urology
dc.sourceScopus
dc.subjectDoxorubicin
dc.subjectIfosfamide
dc.subjectPathological response
dc.subjectSurvival
dc.subjectSynovial sarcoma
dc.subjectSyt-ssx
dc.subjectAdult
dc.subjectAntineoplastic combined chemotherapy protocols
dc.subjectCombined modality therapy
dc.subjectHumans
dc.subjectKidney neoplasms
dc.subjectLebanon
dc.subjectMale
dc.subjectSarcoma, synovial
dc.subjectTertiary care centers
dc.subjectTreatment outcome
dc.subjectCd56 antigen
dc.subjectProtein bcl 2
dc.subjectVimentin
dc.subjectAntineoplastic agent
dc.subjectAdjuvant chemotherapy
dc.subjectAdjuvant therapy
dc.subjectArticle
dc.subjectCancer recurrence
dc.subjectCase report
dc.subjectClinical article
dc.subjectClinical feature
dc.subjectComputer assisted tomography
dc.subjectContrast-enhanced ultrasound
dc.subjectFlank pain
dc.subjectFollow up
dc.subjectFusion gene
dc.subjectHematuria
dc.subjectHuman
dc.subjectImmunohistochemistry
dc.subjectKidney sarcoma
dc.subjectKidney tumor
dc.subjectLebanese
dc.subjectLung metastasis
dc.subjectLymph node dissection
dc.subjectMultiple cycle treatment
dc.subjectNephroblastoma
dc.subjectPrimary tumor
dc.subjectRadical nephrectomy
dc.subjectRenal cell carcinoma
dc.subjectSyt ssx gene
dc.subjectTertiary care center
dc.subjectTumor invasion
dc.subjectTumor volume
dc.subjectWedge resection
dc.subjectMultimodality cancer therapy
dc.subjectPathology
dc.subjectProcedures
dc.titlePrimary synovial sarcoma of the kidney: A case report of complete pathological response at a Lebanese tertiary care center
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2018-8270.pdf
Size:
1.04 MB
Format:
Adobe Portable Document Format